Serious adverse events following immunization and predictors of mortality associated with COVID-19 vaccination in India: a secondary data analysis of nationwide causality assessments.

ABSTRACT:

Background

Vaccines against COVID-19 were viewed as a way out to the ongoing pandemic and were given the emergency use authorization in India to initiate mass vaccination in January 2021. This study aimed to investigate the serious adverse events following immunizations (AEFIs) reported for COVID-19 vaccines and to identify predictors of mortality among these cases from India.

Methods

A secondary data analysis was conducted on the causality assessment reports for the 2708 serious AEFIs published by the National AEFI Committee under the Immunization Division, Ministry of Health and Family Welfare, Government of India. The analysis included all 21 reports published up until May 2023. The primary outcome variable analyzed was the survival/death status of each AEFI case, with va

SUBMITTER: Rajan AK 

PROVIDER: S-EPMC11873861 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature